Updates

Equals

May 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

I spoke to CEO Ian Strafford-Taylor post FY20 results. These show that Equals has pivoted from being a B2C travel business to being a B2B dominated international payment business. B2C revenue was down 30% to £8.7m, with both International Payments and Cash & Retail Cards adversely impacted by the COVID-19-related disruption to travel.B2B revenue rose 9% to £20.3m of which International Payments saw strong growth with revenues of £13.6m. Basically these days Equals’ mainstay is to execute secure ‘spot, futures & forward’ forex contracts for SMEs with its bank grade “straight-through processing” at lower cost than incumbent bank providers - generating a fee per transaction as we ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Bango - Playing the growth of digital ad-spend

Volex - Significant beat on FY21 estimates

Equals Group (February 2024)

Equals (October 2023)

Equals (August 2023)

Equals - Scope for material outperformance (June 2023)

Equals - Forecasts upgraded by 16% (April 2023)

Equals Group - Sales pivot to B2B - now 66% sales (November 2020)

Equals Group (March 2020)

Equals Group (November 2019)

Equals Group - Placing and open offer to raise Â£16m (September 2019)

Equals Group - New name for FairFX (July 2019)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X